T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Microsoft
MSFT
|
+$3.68B |
| 2 |
Pinterest
PINS
|
+$2.14B |
| 3 |
Zoom
ZM
|
+$2.05B |
| 4 |
T-Mobile US
TMUS
|
+$1.98B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.78B |
Top Sells
| 1 |
Alibaba
BABA
|
+$3.74B |
| 2 |
Caterpillar
CAT
|
+$1.25B |
| 3 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.24B |
| 4 |
Netflix
NFLX
|
+$1.22B |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$1.11B |
Sector Composition
| 1 | Technology | 24.62% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 15.3% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Technology Select Sector SPDR Fund
XLK
$84.7B
| $251K | ﹤0.01% |
1,700
| – | – |
|
|
NAGE
2627
Niagen Bioscience, Inc. Common Stock
NAGE
$754M
| $250K | ﹤0.01% |
25,391
+7,113
| +39% | +$70K |
|
2628
GoodRx Holdings
GDRX
$1.43B
| $248K | ﹤0.01% |
6,900
-600
| -8% | -$21.6K |
|
2629
Children's Place
PLCE
$143M
| $248K | ﹤0.01% |
+2,662
| New | +$248K |
|
2630
VirnetX
VHC
$82.3M
| $248K | ﹤0.01% |
2,907
+577
| +25% | +$49.2K |
|
2631
Axogen
AXGN
$738M
| $247K | ﹤0.01% |
11,425
+825
| +8% | +$17.8K |
|
2632
Rigel Pharmaceuticals
RIGL
$644M
| $247K | ﹤0.01% |
5,685
+1,290
| +29% | +$56K |
|
|
SLCA
2633
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $247K | ﹤0.01% |
21,338
-2,922
| -12% | -$33.8K |
|
|
AGEN
2634
Agenus
AGEN
$162M
| $245K | ﹤0.01% |
2,277
+327
| +17% | +$35.2K |
|
2635
Western New England Bancorp
WNEB
$251M
| $245K | ﹤0.01% |
30,100
+4,456
| +17% | +$36.3K |
|
|
CAI
2636
DELISTED
CAI International, Inc.
CAI
| $245K | ﹤0.01% |
+4,377
| New | +$245K |
|
2637
Universal Technical Institute
UTI
$1.5B
| $242K | ﹤0.01% |
37,300
-2,198
| -6% | -$14.3K |
|
2638
Rockwell Medical
RMTI
$62M
| $242K | ﹤0.01% |
24,172
-4,639
| -16% | -$46.4K |
|
2639
Clarus
CLAR
$150M
| $241K | ﹤0.01% |
+9,395
| New | +$241K |
|
2640
Mercer International
MERC
$214M
| $241K | ﹤0.01% |
18,925
-82
| -0.4% | -$1.04K |
|
2641
MVB Financial
MVBF
$306M
| $241K | ﹤0.01% |
+5,650
| New | +$241K |
|
2642
Olema Pharmaceuticals
OLMA
$511M
| $241K | ﹤0.01% |
8,623
+173
| +2% | +$4.84K |
|
2643
Geron
GERN
$868M
| $239K | ﹤0.01% |
169,730
+3,555
| +2% | +$5.01K |
|
2644
Nabors Industries
NBR
$570M
| $238K | ﹤0.01% |
2,084
-163
| -7% | -$18.6K |
|
2645
Nkarta
NKTX
$151M
| $238K | ﹤0.01% |
7,498
-541,970
| -99% | -$17.2M |
|
2646
Brookfield Infrastructure
BIPC
$4.78B
| $235K | ﹤0.01% |
+4,685
| New | +$235K |
|
2647
FRP Holdings
FRPH
$489M
| $235K | ﹤0.01% |
8,436
+138
| +2% | +$3.84K |
|
2648
Wave Life Sciences
WVE
$1.19B
| $234K | ﹤0.01% |
35,082
+4,794
| +16% | +$32K |
|
|
TGH
2649
DELISTED
Textainer Group Holdings limited
TGH
| $234K | ﹤0.01% |
+6,940
| New | +$234K |
|
2650
Acacia Research
ACTG
$309M
| $233K | ﹤0.01% |
34,395
-4,000
| -10% | -$27.1K |
|